Skip to main content
HIT
NASDAQ Finance

Health In Tech Reports Strong 71% Revenue Growth to $33.3M in 2025, Net Income Up 91%

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
8
Price
$1.62
Mkt Cap
$103.005M
52W Low
$0.512
52W High
$4.02
Market data snapshot near publication time

summarizeSummary

Health In Tech, Inc. delivered robust financial results for fiscal year 2025, demonstrating significant growth across key metrics. The substantial increase in revenue, net income, and Adjusted EBITDA indicates strong operational performance and market penetration. The company's strategic focus on its AI-enabled platform, eDIYBS, is driving efficiency and customer expansion, as evidenced by the 23% growth in enrolled employees. While the expansion of the 2024 Equity Incentive Plan introduces potential dilution, it is positioned to support future growth initiatives and attract talent. The detailed disclosure on AI usage risks and the implementation of a governance policy reflect a proactive approach to managing emerging technological challenges. The appointment of several new C-suite executives further strengthens the management team for continued expansion.


check_boxKey Events

  • Strong Revenue Growth in 2025

    Total revenues increased by 71.0% to $33.3 million for the year ended December 31, 2025, up from $19.5 million in 2024.

  • Significant Net Income and Adjusted EBITDA Increase

    Net income grew 90.7% to $1.28 million in 2025 from $0.67 million in 2024. Adjusted EBITDA also saw an 81.1% increase to $4.11 million from $2.27 million year-over-year.

  • Customer Base Expansion

    The number of enrolled employees (EEs) increased by 23% to 22,515 as of December 31, 2025, reflecting strong market demand and channel expansion.

  • Equity Incentive Plan Expansion

    The 2024 Equity Incentive Plan was amended to authorize an additional 3 million Class A common shares and include up to 2 million Class B common shares, potentially diluting existing shareholders but supporting future growth.


auto_awesomeAnalysis

Health In Tech, Inc. delivered robust financial results for fiscal year 2025, demonstrating significant growth across key metrics. The substantial increase in revenue, net income, and Adjusted EBITDA indicates strong operational performance and market penetration. The company's strategic focus on its AI-enabled platform, eDIYBS, is driving efficiency and customer expansion, as evidenced by the 23% growth in enrolled employees. While the expansion of the 2024 Equity Incentive Plan introduces potential dilution, it is positioned to support future growth initiatives and attract talent. The detailed disclosure on AI usage risks and the implementation of a governance policy reflect a proactive approach to managing emerging technological challenges. The appointment of several new C-suite executives further strengthens the management team for continued expansion.

この提出時点で、HITは$1.62で取引されており、市場はNASDAQ、セクターはFinance、時価総額は約$1億でした。 52週の取引レンジは$0.51から$4.02でした。 この提出書類はポジティブの市場センチメント、重要度スコア8/10と評価されました。

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed HIT - Latest Insights

HIT
Apr 24, 2026, 5:06 PM EDT
Filing Type: S-3
Importance Score:
7
HIT
Mar 26, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
8
HIT
Mar 25, 2026, 5:29 PM EDT
Filing Type: 10-K
Importance Score:
8
HIT
Mar 25, 2026, 5:06 PM EDT
Filing Type: 8-K
Importance Score:
7
HIT
Mar 25, 2026, 4:17 PM EDT
Source: Dow Jones Newswires
Importance Score:
7